Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


Articles published in Br J Cancer

Retrieve available abstracts of 19 articles:
HTML format
Text format



Single Articles


    July 2018
  1. SMITTENAAR P, Walker AK, McGill S, Kartsonaki C, et al
    Harnessing citizen science through mobile phone technology to screen for immunohistochemical biomarkers in bladder cancer.
    Br J Cancer. 2018 Jul 11. pii: 10.1038/s41416-018-0156.
    PubMed     Text format     Abstract available


    May 2018
  2. MASON SJ, Downing A, Wright P, Hounsome L, et al
    Health-related quality of life after treatment for bladder cancer in England.
    Br J Cancer. 2018 May 14. pii: 10.1038/s41416-018-0084.
    PubMed     Text format     Abstract available


    February 2018
  3. SAKAGUCHI T, Yoshino H, Yonemori M, Miyamoto K, et al
    Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.
    Br J Cancer. 2018 Feb 13. pii: bjc2017439. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    November 2017
  4. KASHIWAGI E, Inoue S, Mizushima T, Chen J, et al
    Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression.
    Br J Cancer. 2017 Nov 9. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    October 2017
  5. MORERA DS, Hennig MS, Talukder A, Lokeshwar SD, et al
    Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets.
    Br J Cancer. 2017 Oct 3. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    September 2017
  6. KOSHIARIS C, Aveyard P, Oke J, Ryan R, et al
    Smoking cessation and survival in lung, upper aero-digestive tract and bladder cancer: cohort study.
    Br J Cancer. 2017 Sep 12. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    July 2017
  7. DESCOTES F, Kara N, Decaussin-Petrucci M, Piaton E, et al
    Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine.
    Br J Cancer. 2017 Jul 6. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    March 2017
  8. SAKAGUCHI T, Yoshino H, Yonemori M, Miyamoto K, et al
    Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.
    Br J Cancer. 2017 Mar 21. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    January 2017
  9. CHOUDHURY A, West CM, Porta N, Hall E, et al
    The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004).
    Br J Cancer. 2017 Jan 26. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    December 2016
  10. PARDINI B, Viberti C, Naccarati A, Allione A, et al
    Increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of bladder cancer.
    Br J Cancer. 2016 Dec 13. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


    July 2016
  11. IRLAM-JONES JJ, Eustace A, Denley H, Choudhury A, et al
    Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer.
    Br J Cancer. 2016 Jul 21. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


    June 2016
  12. MIYAMOTO K, Seki N, Matsushita R, Yonemori M, et al
    Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer.
    Br J Cancer. 2016 Jun 16. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


    February 2016
  13. SAPRE N, Macintyre G, Clarkson M, Naeem H, et al
    A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance.
    Br J Cancer. 2016;114:454-62.
    PubMed     Text format     Abstract available


  14. WANG W, Chen H, Liu Z, Qu P, et al
    Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
    Br J Cancer. 2016;114:305-13.
    PubMed     Text format     Abstract available


    December 2015
  15. BHINDI B, Hermanns T, Wei Y, Yu J, et al
    Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy.
    Br J Cancer. 2015 Dec 10. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


    July 2015
  16. BLICK C, Ramachandran A, McCormick R, Wigfield S, et al
    Identification of a hypoxia-regulated miRNA signature in bladder cancer and a role for miR-145 in hypoxia-dependent apoptosis.
    Br J Cancer. 2015 Jul 21. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


    June 2015
  17. KHADJAVI A, Mannu F, Destefanis P, Sacerdote C, et al
    Early diagnosis of bladder cancer through the detection of urinary tyrosine-phosphorylated proteins.
    Br J Cancer. 2015 Jun 30. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  18. MATSUSHITA R, Seki N, Chiyomaru T, Inoguchi S, et al
    Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer.
    Br J Cancer. 2015 Jun 9. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


    May 2015
  19. TURATI F, Polesel J, Di Maso M, Montella M, et al
    Diabetes mellitus and the risk of bladder cancer: an Italian case-control study.
    Br J Cancer. 2015 May 21. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: